The global human papillomavirus protein E7 market is expected to grow at a significant CAGR during the forecast period (2022-2028). Human papillomavirus (HPV) infections are a collection of skin infections that affect the anus, cervix, and mouth, among other regions of the body. People of various ages are discovered to be affected by various types of warts. The most common and contagious of all warts, genital warts spread by skin-to-skin contact. In children, warts are frequently left untreated. In rare circumstances, warts can be removed by applying drugs directly to the lesions. In order to prevent future infections, HPV vaccination is suggested, however, it is not a treatment.

The infected virus by entering the body by a cut, abrasion, or a small tear in the skin. Skin-to-skin contact is the most common way for the virus to spread. In the 1990s, epidemiologic studies indicating a consistent link between HPV and cervical cancer were published; more recently, HPV has been linked to other mucosal malignancies. In the US, a quadrivalent vaccination to prevent infection with four forms of HPV was approved in 2006, followed by a bivalent vaccine in 2009 and a 9-valent vaccine in 2014. The Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute (NCI) and the National Program of Cancer Registries of the Centers for Disease Control and Prevention (CDC) offer data on the number of HPV malignancies in the US. The rise in the number of infections caused by HPV is contributing to the growth of the market. Annually, as per CDC, 43,999 HPV-related malignancies are reported, including 24,886 cases in women and 19,113 cases in men. The most prevalent diseases linked to HPV are projected to be 10,900 cervical cancers in women and 11,300 oropharyngeal cancers in males, according to gender. HPV is also responsible for 91% of anal cancers, 69% of vulvar cancers, 75% of vaginal cancers, 63% of penile cancers, and 70% of oropharyngeal cancers, in addition to cervical cancer.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type 
• By Application 

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Inovio Pharmaceuticals, Inc., and Genexine, Inc., among others. 

• Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Human Papillomavirus Protein E7 Market Report by Segment

By Type  

• CUE-201
• BLSILSB-710c
• Others 

By Application 

• Anal Cancer
• Lung Cancer
• Penile Cancer
• Rectal Cancer
• Others

Global Human Papillomavirus Protein E7 Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa